"Volumetrix is a tremendous step forward in helping our customers prepare for the next frontier in molecular imaging," said Nathan Hermony, nuclear medicine general manager, GE Healthcare. "We believe that Volumetrix Suite will bring clinicians the power of the 'three C's' of imaging: Clarity, Choice, and Convenience."

See further information in DOTmed Online News at https://www.dotmed.com/news/story/6287/

PET/CT
Motion is the most significant clinical challenge in PET/CT. GE Healthcare continues the journey toward MotionFree PET/CT imaging with advanced motion correction techniques offered as part of its Discovery PET/CT platform. With GE's offerings, clinicians now have more information and tools to help them diagnose and stage with accuracy, plan with precision and monitor with confidence.

"GE is a leader in PET/CT," said Henry Hummel, global PET/CT general manager, GE Healthcare. "And we've continued to make every new technology clinically relevant. From providing the highest sensitivity crystals for outstanding lesion detectability, to motion-correction techniques to address the biggest clinical challenge in PET/CT, we are constantly looking at ways to help physicians help patients."

Highlighting GE's PET/CT presence at SNM 2008 was the Discovery platform, optimized for advanced clinical applications. The Discovery series of PET/CT scanners feature industry-leading sensitivity and VUE Point HD high-definition imaging, with improved signal-to-noise ratio (SNR) for all PET/CT exams.
"Our crystal technology and VUE Point HD reconstruction have been a tremendous asset for our platform to provide clinicians field-leading sensitivity and high-definition imaging," said Hummel. "We continue to innovate, while keeping in place the key platform components that deliver robust clinical capabilities."

Pre-clinical Imaging
The molecular imaging revolution extends to GE's pre-clinical imaging products. The new eXplore speCZT, the first full-ring solid-state detector small animal SPECT, utilizes a cadmium zinc telluride (CZT) detector, allowing for full 360-degree coverage around the animal and high-energy resolution to enable dual or triple radio-nuclide imaging. The increased sensitivity of speCZT helps medical researchers perform dynamic small animal SPECT imaging to precisely quantify radiotracer uptake and identify morphological changes.

Radiopharmacy
Molecular imaging is only possible with the latest in contrast agents and radiopharmaceuticals. GE's FASTlab, also featured at SNM 2008, was the first multi-tracer PET chemistry synthesis platform to feature a cassette that incorporates pre-measured, pre-loaded reagents-a dramatic innovation that delivers higher yields, improved reproducibility and faster synthesis.

More Industry Headlines